Phase XIV, group 3 - 01.09.2022 - 30.08.2025

Ca.-No 206

Defining the mechanisms of Wnt secretion and function in the bloodstream in health and cancer

Israeli Partner: Rina Rosin-Arbesfeld, Tel Aviv University
German Partner: Michael Boutros, DKFZ

Ca.-No 207

Anti-metastatic therapy by making the host hostile

Israeli Partner: Eithan Galun, Hadassah Hebrew University Hospital
German Partner: Rene-Filip Jackstadt, DKFZ, HI-STEM Heiko Hermeking, DKTK München

Ca.-No 208

Cellular senescence and the interferon response in cancer

Israeli Partner: Ittai Ben-Porath, Hebrew University
German Partner: Chong Sun, DKFZ

Ca.-No 209

Role of p53 in metabolic reprogramming breast cancer adjacent

Israeli Partner: Moshe Oren, Weizmann Institute
German Partner: Almut Schulze, DKFZ

Ca.-No 210

Mechanistic elucidation of vaginal microbiome impacts on human papillomavirus driven cervical cancer

Israeli Partner: Ahinoam Lev-Sagie, Hadassah Medical Center
German Partner: Eran Elinav, DKFZ

Ca.-No 211

Clonal dynamics of aging hematopoiesis in humans

Israeli Partner: Liran Shlush, Weizmann Institute
German Partner: Thomas Höfer, DKFZ

Formular

Formulardaten werden geladen ...